卫生系统绩效评估对于决策者来说是一个具有挑战性的过程。就哈萨克斯坦的医疗保健系统而言，迄今为止尚未得到充分利用的可避免死亡率的计算可以作为确定需要改进的优先领域的额外工具。因此，本研究的目的是分析哈萨克斯坦可避免的死亡率。数据取自哈萨克斯坦国家统计局。它涵盖了按年龄划分的人口数据，以及基于经合组织（经济合作与发展组织）/欧盟统计局对可预防和可治疗死亡原因的联合分类的疾病组死亡率的人口数据。数据涵盖 2015 年至 2021 年，按性别和 5 岁年龄组（0、1-4、5-9、...、70-74）分类。使用 2015 年 OECD 标准人口进行标准化。我们使用连接点回归分析来计算平均年百分比变化（AAPC）。2015年至2019年，每10万人口可避免死亡率的年百分比变化（APC）为-3.8（-5.7至-1.8），2019至2019年每10万人口可避免死亡率的年百分比变化（APC）为-3.8（-5.7至-1.8）。 2021 年增加了 17.6（11.3 至 24.3）。与女性相比，男性表现出更高的可避免死亡率。可预防的死亡率始终高于可治疗的死亡率。从2015年到2019年，可预防的和可治疗的死亡率都降低，可预防的死亡率达到272.17，然后在2021年上升到每100万人的379.23人口。在2015年至2021年之间，可治疗的死亡率从179.3（176.93-181.67）提高到205.45（203.08-207.81）。每 10 万人中的死亡率。在哈萨克斯坦，可避免的死亡的主要原因是循环系统疾病、呼吸道疾病和癌症。为了实现全民健康覆盖（UHC）的目标并改善总体人口健康，迫切需要改进医疗保健体系并降低可避免的死亡率。虽然承认 COVID-19 对这些趋势的影响很重要，但我们的研究重点关注可避免的死亡率，提供了宝贵的见解，补充了对流行病相关影响的理解。© 2024由克尔曼医科大学出版这是一篇根据知识共享署名许可证 (http://creativecommons.org/licenses/by/4.0) 条款分发的开放获取文章，允许不受限制地使用、分发和复制任何媒体，只要正确引用原始作品即可。

The health system performance assessment is a challenging process for decision-makers. In case of Kazakhstan's healthcare system, the calculation of avoidable mortality, which has been underutilized to date, could serve as an additional tool to prioritize areas for improvement. Therefore, the aim of the study is to analyse avoidable mortality in Kazakhstan.The data was retrieved from the Bureau of National Statistics, Kazakhstan. It covers population data by age, mortality rates from disease groups based on the Joint OECD (Organisation for Economic Co-operation and Development)/Eurostat classification of preventable and treatable causes of mortality. The data spans from 2015 to 2021, categorized by gender and 5-year age groups (0, 1-4, 5-9, ..., 70-74). Standardization was performed using the 2015 OECD standard population. We used joinpoint regression analysis to calculate the average annual percentage change (AAPC).From 2015 to 2019, the annual percentage change (APC) in avoidable mortality per 100 000 population was -3.8 (-5.7 to -1.8), and from 2019 to 2021 it increased by 17.6 (11.3 to 24.3). Males exhibited higher avoidable mortality rates compared to females. The preventable mortality rate was consistently higher than the treatable mortality. Both preventable and treatable mortality decreased from 2015 to 2019, with preventable mortality reaching 272.17 before rising to 379.23 per 100 000 population in 2021. Between 2015 and 2021, treatable mortality rates increased from 179.3 (176.93-181.67) to 205.45 (203.08-207.81) per 100 000 population.In Kazakhstan, the leading causes of avoidable mortality were circulatory diseases, respiratory diseases, and cancer. To achieve the goals of universal health coverage (UHC) and improve the overall population health, there is an urgent need to amend the healthcare system and reduce avoidable mortality. While it is important to acknowledge the influence of COVID-19 on these trends, our study's focus on avoidable mortality provides valuable insights that complement the understanding of pandemic-related effects.© 2024 The Author(s); Published by Kerman University of Medical Sciences This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.